CELU - Celularity - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

118.7M

Cash

273K

Avg Qtr Burn

-15.98M

Short % of Float

7.60%

Insider Ownership

50.95%

Institutional Own.

14.38%

Qtr Updated

09/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
PDA-002 Details Facioscapulohumeral muscular dystrophy	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.